Skip to main content
Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal will invite guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 1, 2012

Articles

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
pp. 27-33(7)
Authors: Garofalo, M.; Quintavalle, C.; Romano, G.; M. Croce, C.; Condorelli, G.

Favourites:
ADD

Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
pp. 34-49(16)
Authors: Aggarwal, R.; Lu, J.; J. Pompili, V.; Das, H.

Favourites:
ADD

Nitric Oxide and Cancer: The Emerging Role of S-Nitrosylation
pp. 50-67(18)
Authors: Aranda, E.; Lopez-Pedrera, C.; R. De La Haba-Rodriguez, J.; Rodriguez-Ariza, A.

Favourites:
ADD

The Emerging Role of Endocrine Disruptors in Pathogenesis of Insulin Resistance: A Concept Implicating Nonalcoholic Fatty Liver Disease
pp. 68-82(15)
Authors: A. Polyzos, S.; Kountouras, J.; Deretzi, G.; Zavos, C.; S. Mantzoros, C.

Favourites:
ADD

HCV Infection by Cell-to-Cell Transmission: Choice or Necessity?
pp. 83-95(13)
Authors: Carloni, G.; Crema, A.; B. Valli, M.; Ponzetto, A.; Clementi, M.

Favourites:
ADD

Open Access Basal Breast Cancer: A Complex and Deadly Molecular Subtype
pp. 96-110(15)
Authors: Bertucci, F.; Finetti, P.; Birnbaum, D.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content